Spandidos Publications style
An S, Lin Q, Chen Z, Su J, Cheng H, Xie Z, Zhang X, Zhou H, Huang Y, Chen S, Chen S, et al: Combinations of laminin 5 with PTEN, p-EGFR and p-Akt define a group of distinct molecular subsets indicative of poor prognosis in patients with non-small cell lung cancer. Exp Ther Med 4: 226-230, 2012.
APA
An, S., Lin, Q., Chen, Z., Su, J., Cheng, H., Xie, Z. ... Wu, Y. (2012). Combinations of laminin 5 with PTEN, p-EGFR and p-Akt define a group of distinct molecular subsets indicative of poor prognosis in patients with non-small cell lung cancer. Experimental and Therapeutic Medicine, 4, 226-230. https://doi.org/10.3892/etm.2012.577
MLA
An, S., Lin, Q., Chen, Z., Su, J., Cheng, H., Xie, Z., Zhang, X., Zhou, H., Huang, Y., Chen, S., Guo, W., Wu, Y."Combinations of laminin 5 with PTEN, p-EGFR and p-Akt define a group of distinct molecular subsets indicative of poor prognosis in patients with non-small cell lung cancer". Experimental and Therapeutic Medicine 4.2 (2012): 226-230.
Chicago
An, S., Lin, Q., Chen, Z., Su, J., Cheng, H., Xie, Z., Zhang, X., Zhou, H., Huang, Y., Chen, S., Guo, W., Wu, Y."Combinations of laminin 5 with PTEN, p-EGFR and p-Akt define a group of distinct molecular subsets indicative of poor prognosis in patients with non-small cell lung cancer". Experimental and Therapeutic Medicine 4, no. 2 (2012): 226-230. https://doi.org/10.3892/etm.2012.577
